Key failure to deliver metrics for GlaxoSmithKline:
Last SEC data release: 2024-04-30
Last 15 days FTD volume: $2.46 M
Last 3 months FTD volume: $18.31 M
Last year FTD volume: $24.09 M
A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations.
FTDs for US listed companies are reported to the SEC and published twice a month.
Therefore there is a certain delay between the reporting and the publishing of the data.
Failures to deliver for GlaxoSmithKline (GSK) - 3 months history
Number of shares, 3 months chart
Biweekly Failures to deliver volume for GlaxoSmithKline (GSK) - since 2022
Volume in USD (price x number of shares), data since 2022
GlaxoSmithKline (GSK) Failure to deliver volume, Year over Year
Year
Volume (Price x Shares)
Change
2024
$18.87 M
-36.88%
2023
$29.9 M
-43.98%
2022
$53.37 M
FTD volume in the last 3 months for similar companies or competitors